Bivalent ligand type beta-adrenolytics related to practolol
Rampa, A.; Da Re, P.; Valenti, P.; Frigeni, V.; Sala, R.; Della Bella, D.
Drugs under Experimental and Clinical Research 14(9): 581-586
1988
ISSN/ISBN: 0378-6501 PMID: 2906585 Document Number: 321436
The synthesis and pharmacological evaluation of a number of symmetrical bivalent ligand type beta-adrenolytics related to practolol are reported. The best results have been observed with N,N'-bis[3-[2-hydroxy-3-[1-methylethyl)amino]propoxy]phenyl] ethanediamide.
Document emailed within 1 workday
Related Documents
Mardarowicz, G.; Lopatyński, J. 1987: Use of beta-adrenolytics in the treatment of thyrotoxicosis Polski Tygodnik Lekarski 42(36): 1099-1103Cizmáriková, R.; Pazin, E.; Hricková 1992: Histologic evaluation of potential new beta-adrenolytics Ceskoslovenska Farmacie 41(7-8): 264-265
Lasek, R.; Fischer, W.; Müller, M. 1983: Anticonvulsant activity of beta-adrenolytics in electroshock Die Pharmazie 38(3): 202-203
Grodzińska, L.; Gryglewski, R. 1971: Action of beta-adrenolytics on the isolated guinea-pig atria Archives Internationales de Pharmacodynamie et de Therapie 191(1): 133-141
Pisarek-Miedzińska, D.; Czech, W. 1991: Use of beta-adrenolytics in treatment of hyperthyroidism in pregnant women Polski Tygodnik Lekarski 46(17-18): 323-324
Racanská, E.; Kozlovský, J. 1994: Pharmacologic evaluation of p-hydroxyacetophenone derivatives as potential beta-adrenolytics Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 43(4): 169-170
Cizmáriková, R.; Racanská, E.; Greksáková, O. 1993: Changes in basic nitrogen in a group of potential new beta- adrenolytics--derivatives of p-hydroxyacetophenone and p-hydroxypropiofenone Ceskoslovenska Farmacie 42(2): 82-85
De Jong, J.L.; Farner, N.L.; Widmer, M.B.; Giri, J.G.; Sondel, P.M. 1996: Interaction of IL-15 with the shared IL-2 receptor beta and gamma c subunits. the IL-15/beta/gamma c receptor-ligand complex is less stable than the IL-2/beta/gamma c receptor-ligand complex Journal of Immunology 156(4): 1339-1348
Kim, C.H.; Pelus, L.M.; White, J.R.; Applebaum, E.; Johanson, K.; Broxmeyer, H.E. 1998: CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells Journal of Immunology 160(5): 2418-2424
Ambrosioni, E.; Bracchetti, D.; Russo, F.; Catizone, L.; Perri, G.; Magnani, B. 1972: Comparison of the hemodynamic effects in man of 2 beta-blockaders: propranolol and practolol Bollettino Della Societa Italiana di Cardiologia 17(2): 91-101
Levy, B. 1973: Practolol blockade of cardiac but not vascular or uterine beta-adrenergic receptors in the anesthetized cat Archives Internationales de Pharmacodynamie et de Therapie 204(1): 143-146
Stephan, K.; Meesmann, W.; Amann, L.; Tacke, E.; Tüttemann, J. 1972: Effects of a heart specific beta blockader (practolol) following acute experimental coronary occlusion Verhandlungen der Deutschen Gesellschaft für Innere Medizin 78: 1029-1033
Erikssen, J.; Rod, T. 1971: Treatment of angina pectoris with cardioselective beta blocking agents. Double blind study with Eraldin (practolol) Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 91(10): 721-725
Bischoff, K.; Larsen, N.; Mucha, C.; Westermann, K.W. 1976: Reaction of peripheral veins and arteries following administration of beta-active agents. Studies on isoproterenol, propranolol, and practolol Medizinische Klinik 71(30): 1239-1243
Di Luzio, V.; Purcaro, A.; Curzi, G.; Di Segni, E.; Chiesa, R.; Di Giuseppe, F. 1972: Effects on the contractile state of the myocardium and anti-arrhythmic properties of practolol, a beta-blocking agent with cardioselective activity Bollettino Della Societa Italiana di Cardiologia 17(3): 179-187
Adamska-Dyniewska, H. 1973: Changes in effort tolerance in patients with coronary arterial disease following administration of 4 beta-adrenolytic agents (propranolol, visken, oxyprenolol and practolol) Wiadomosci Lekarskie 26(13): 1201-1205
Pacifici, R.; Roman, J.; Kimble, R.; Civitelli, R.; Brownfield, C.M.; Bizzarri, C. 1994: Ligand binding to monocyte alpha 5 beta 1 integrin activates the alpha 2 beta 1 receptor via the alpha 5 subunit cytoplasmic domain and protein kinase C Journal of Immunology 153(5): 2222-2233
Miyazaki, M.; Nioka, S.; Fujita, T. 1975: Use of various beta-adrenergic blockers in clinical anesthesia. (5) Clinical and experimental use of practolol (Eraldin) Masui. Japanese Journal of Anesthesiology 24(1): 56-63
Schmid, P.; Cox, D.; van der Putten, H.; McMaster, G.K.; Bilbe, G. 1994: Expression of TGF-beta s and TGF-beta type II receptor mRNAs in mouse folliculogenesis: stored maternal TGF-beta 2 message in oocytes Biochemical and Biophysical Research Communications 201(2): 649-656
Floru, L.; Tegeler, J. 1974: Therapeutic significance of the beta-receptor blockade in lithium-induced tremor. Therapeutic trials with Pindolol and Practolol Die Medizinische Welt 25(11): 450